Development and validation of a questionnaire to assess delay in treatment for breast cancer

BMC Cancer

Karla Unger-Saldaña³  Ingris Peláez-Ballestas¹  Claudia Infante-Castañeda² 

[1] Rheumatology Department, Hospital General de México, Mexico City, Mexico

[2] Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico

[3] Faculty of Medicine, Universidad Nacional Autónoma de México & Instituto Nacional de Cancerología de México, Mexico City, Mexico

关键词: Reliability;    Validity;    Questionnaire;    Delayed medical care;    Breast cancer;   

Others  :  1079991
DOI  :  10.1186/1471-2407-12-626

 received in 2012-04-24, accepted in 2012-12-18,  发布年份 2012

【 摘 要 】

Background

This study reports the reliability and validity of a questionnaire designed to measure the time from detection of a breast cancer to arrival at a cancer hospital, as well as the factors that are associated with delay.

Methods

The proposed questionnaire measures dates for estimation of the patient, provider and total intervals from detection to treatment, as well as factors that could be related to delays: means of problem identification (self-discovery or screening), the patients’ initial interpretations of symptoms, patients’ perceptions of delay, reasons for delay in initial seeking of medical care, barriers perceived to have caused provider delay, prior utilisation of health services, use of alternative medicine, cancer-screening knowledge and practices, and aspects of the social network of support for medical attention. The questionnaire was assembled with consideration for previous research results from a review of the literature and qualitative interviews of patients with breast cancer symptoms. It was tested for face validity, content validity, reliability, internal consistency, convergent and divergent validity, sensitivity and specificity in a series of 4 tests with 602 patients.

Results

The instrument showed good face and content validity. It allowed discrimination of patients with different types and degrees of delay, had quite good reliability for the time intervals (with no significant mean differences between the two measurements), and fairly good internal consistency of the item dimensions (with Cronbach’s alpha values for each dimension between 0.42 and 0.85). Finally, sensitivity and specificity were 74.68% and 48.81%, respectively.

Conclusions

To the best of our knowledge, this is the first published report of the development and validation of a questionnaire for estimation of breast cancer delay and its correlated factors. It is a valid, reliable and sensitive instrument.

【 授权许可】

   
2012 Unger-Saldaña et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v1.2. IARC CancerBase No 10. Int Agency Res Cancer: Cancer incidence and mortality worldwide; 2010.
• [2]American Cancer Society: Breast Cancer Facts and Figures. American Cancer Society, Inc: Atlanta; 2009–2010.
• [3]Dirección General de Epidemiología (DGE): Base de datos del Registro Histopatológico de Neoplasias Malignas 2004–2006 (RHNM). México: Secretaría de Salud: Sistema Nacional de Vigilancia Epidemiológica (SINAVE); 2004–2006.
• [4]Mohar A, Bargallo E, Ramirez MT, Lara F, Beltran-Ortega A: Available resources for the treatment of breast cancer in Mexico]. Salud Publica Mex 2009, 51(2):s263-269.
• [5]López-Carrillo LS-LL, Torres-Sánchez L: Breast cancer examination in Mexico: summary of the results from the National Survey of Reproductive Health. Salud Publica Mex 2009, 51(2):s345-349.
• [6]Unger-Saldaña K, Infante-Castañeda C: Is Breast Cancer Delay really the patient’s fault? In Relational Concepts in Medicine. Oxford, United Kingdom: Interdisciplinary Net: 1st edition. Edited by Deng M, Raia F, Vaccarella M; 2011.
• [7]Facione NC: Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med 1993, 36(12):1521-1534.
• [8]Ramirez AJ, Westcombe AM, Burgess CC, Sutton S, Littlejohns P, Richards MA: Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999, 353(9159):1127-1131.
• [9]Unger-Saldaña K, Infante-Castañeda C: Delay of medical care for symptomatic breast cancer: A literature review. Salud Publica Mex 2009, 51(S2):S270-S285.
• [10]Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A: Delayed presentation in breast cancer: a study in Iranian women. BMC Womens Health 2003, 3(1):4. BioMed Central Full Text
• [11]Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H: Patient delay and stage of diagnosis among breast cancer patients in Germany – a population based study. Br J Cancer 2002, 86(7):1034-1040.
• [12]Burgess CC, Potts HW, Hamed H, Bish AM, Hunter MS, Richards MA, Ramirez AJ: Why do older women delay presentation with breast cancer symptoms? Psychooncology 2006, 15(11):962-968.
• [13]Barber MD, Jack W, Dixon JM: Diagnostic delay in breast cancer. Br J Surg 2004, 91(1):49-53.
• [14]Sainsbury R, Johnston C, Haward B: Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999, 353(9159):1132-1135.
• [15]Montella M, Crispo A, D’Aiuto G, De Marco M, de Bellis G, Fabbrocini G, Pizzorusso M, Tamburini M, Silvestra P: Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev 2001, 10(1):53-59.
• [16]Arndt V, Sturmer T, Stegmaier C, Ziegler H, Becker A, Brenner H: Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol 2003, 21(8):1440-1446.
• [17]Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK: Reasons for delay in breast cancer diagnosis. Prev Med 1996, 25(2):218-224.
• [18]de Nooijer J, Lechner L, de Vries H: Social psychological correlates of paying attention to cancer symptoms and seeking medical help. Soc Sci Med 2003, 56(5):915-920.
• [19]Facione NC, Miaskowski C, Dodd MJ, Paul SM: The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med 2002, 34(4):397-407.
• [20]Burgess CC, Ramirez AJ, Richards MA, Love SB: Who and what influences delayed presentation in breast cancer? Br J Cancer 1998, 77(8):1343-1348.
• [21]Nosarti C, Crayford T, Roberts JV, Elias E, McKenzie K, David AS: Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer 2000, 82(3):742-748.
• [22]Neal RD, Pasterfield D, Wilkinson C, Hood K, Makin M, Lawrence H: Determining patient and primary care delay in the diagnosis of cancer - lessons from a pilot study of patients referred for suspected cancer. BMC Fam Pract 2008, 9:9. BioMed Central Full Text
• [23]Lynch BM, Youlden D, Fritschi L, Newman B, Pakenham KI, Leggett B, Owen N, Aitken JF: Self-reported information on the diagnosis of colorectal cancer was reliable but not necessarily valid. J Clin Epidemiol 2008, 61(5):498-504.
• [24]Samet JM, Hunt WC, Lerchen ML, Goodwin JS: Delay in seeking care for cancer symptoms: a population-based study of elderly New Mexicans. J Natl Cancer Inst 1988, 80(6):432-438.
• [25]Neal RD, Allgar VL: Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer”. Br J Cancer 2005, 92(11):1971-1975.
• [26]Leydon GM, Bynoe-Sutherland J, Coleman MP: The journey towards a cancer diagnosis: the experiences of people with cancer, their family and carers. Eur J Cancer Care (Engl) 2003, 12(4):317-326.
• [27]Hansen R, Olesen F, Sorensen H, Sokolowski I, Sondergaard J: Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res 2008, 8:49. BioMed Central Full Text
• [28]Feinstein AR: Clinimetrics. New Haven: Yale University Press; 1987.
• [29]Andersen R, Vedsted P, Olesen F, Bro F, Soendergaard J: Patient delay in cancer studies: a discussion of methods and measures. BMC Health Serv Res 2009, 9(1):189. BioMed Central Full Text
• [30]Johnson TP, O’Rourke DP, Burris JE, Warnecke RB: An investigation of the effects of social desirability on the validity of self reports of cancer screening behaviors. Med Care 2005, 43(6):565-573.
• [31]Porta M, Malats N, Belloc J, Gallen M, Fernandez E: Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer’s judgement. Eur J Epidemiol 1996, 12(6):553-562.
• [32]Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ: Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 1999, 353(9159):1119-1126.
• [33]Cárdenas-Sánchez J, Sandoval-Guerrero F: Segunda Revisión del Consenso Nacional sobre el diagnóstico y tratamiento del Cáncer Mamario, México 2005. Gaceta Mexicana de Oncología 2006, 5:2.
• [34]Streiner DL, Norman GR: Health measurement scales: a practical guide to their development and use. 2nd edition. Oxford: Oxford Medical Publications; 1995.
• [35]Unger-Saldana K, Infante-Castaneda CB: Breast cancer delay: A grounded model of help-seeking behaviour. Soc Sci Med 2011, 72(7):1096-1104.
• [36]Lopez-Vazquez E, Marvan ML: [Validation of a scale measuring coping with extreme risks]. Salud Publica Mex 2004, 46(3):216-221.
• [37]Gongora E: Los enfrentamientos a los problemas y el papel del control. una visión etnopsicológica en un ecosistema con tradición (Master's degree thesis), Universidad Nacional Autónoma de México (UNAM), Mexico City;
• [38]Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, et al.: The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 2012, 106(7):1262-1267.
• [39]Streiner DL, Norman GR: “Precision” and “accuracy”: two terms that are neither. J Clin Epidemiol 2006, 59(4):327-330.
• [40]Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC: Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007, 60(1):34-42.
• [41]Deveillis R, In Scale Development: Guidelines in scale development. CA: Newbury Park: Theory and applications. Edited by Deveillis R; 1991.
• [42]Mitchell T: The social and emotional toll of chemotherapy - patients’ perspectives. Eur J Cancer Care (Engl) 2007, 16(1):39-47.
• [43]Bright K, Barghash M, Donach M, de la Barrera MG, Schneider RJ, Formenti SC: The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City, Mexico. Breast 2011, 20(Suppl 2):S54-59.
• [44]Piñeros M, Sánchez R, Perry F, García OA, Ocampo R, Cendales R: Demoras en el diagnóstico y tratamiento de mujeres con cáncer de mama en Bogotá. Colombia. Salud Pública de México (In Spanish) 2011, 53:478-485.
• [45]Rezende MC, Koch HA, Figueiredo Jde A, Thuler LC: [Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro]. Revista brasileira de ginecologia e obstetricia: revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2009, 31(2):75-81.